[HTML][HTML] Effect of tocilizumab on mortality in patients with SARS-CoV-2 pneumonia caused by Delta or omicron variants: a propensity-matched analysis in Nimes …

P Laffont-Lozes, D Laureillard, P Loubet, R Stephan… - Antibiotics, 2023 - mdpi.com
We aimed to assess the factors associated with mortality in patients treated with tocilizumab
for a SARS-CoV-2 pneumonia due to the delta or omicron variants of concern (VOC) and …

[HTML][HTML] Predictors of mortality in tocilizumab-treated severe COVID-19

K Pagkratis, S Chrysikos, E Antonakis, A Pandi… - Vaccines, 2022 - mdpi.com
Purpose: Tocilizumab is associated with positive outcomes in severe COVID-19. We wanted
to describe the characteristics of nonresponders to treatment. Methods: This was a …